Close

Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. BA
5. SPOT
6. META
7. V
8. IBM
9. KMB
10. HCP


Go back to Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
(NASDAQ: TYME) Delayed: 0.31 --0 (-0%)
Previous Close $0.31    52 Week High $ 
Open $0.31    52 Week Low $ 
Day High $0.31    P/E N/A 
Day Low $0.31    EPS $ 
Volume 1,700